Jeannette Bankes' departure as President of GE HealthCare Technologies Inc. was reported; the filing names no successor. As of November 6, 2026, GE HealthCare Technologies Inc. has reported 5 leadership change filings to the SEC under Item 5.02 of Form 8-K, from July 23, 2026 to November 5, 2026, naming 3 appointments and 1 departure (Form 8-K, October 28, 2026).
Who owns GE HealthCare Technologies Inc.?
GE HealthCare Technologies Inc. named a new Director on Sep 22. 30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like GE HealthCare Technologies Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-11-05
- · In / out: Out · Person: Jeannette Bankes · Role: President · 8-K, 2026-10-28
- · In / out: In · Person: Pascal Desroches · Role: Director · Effective: 2027-01-04 · 8-K, 2026-09-22
- · In / out: In · Person: William K. Grogan · Role: Chief Financial Officer · Effective: 2026-09-14 · 8-K, 2026-08-18
- · In / out: In · Person: George Newcomb · Role: Chief Financial Officer · Effective: 2026-08-14 · 8-K, 2026-07-23
GE HealthCare Technologies Inc. reported changes in 5 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-23 to 2026-11-05. They name 4 people, with 3 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as GE HealthCare Technologies Inc. files it.
Also on the record for GE HealthCare Technologies Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 7, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 10.5% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 8.3% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Capital Research Global Investors | 4.6% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 6.9% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.31% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Dodge & Cox | 6.9% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G, by Capital Research Global Investors | 5.5% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G, by Dodge & Cox | 5.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs GE HealthCare Technologies Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on GE HealthCare Technologies Inc. and the records around it.
GE HealthCare Technologies Inc. elsewhere on the record
Companies that share a holder
- Dodge & Cox also filed stake reports on 36 other companies: Charter Communications, Inc. (Aug 2026), SUN COMMUNITIES, INC (Aug 2026), TransUnion (Jun 2026)
- Capital Research Global Investors also filed stake reports on 99 other companies: Royal Caribbean Cruises Ltd. (Oct 2026), Patria Investments Ltd. (Sep 2026), Arxis, Inc. (Aug 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
Watch GE HealthCare Technologies Inc.
Get an email when GE HealthCare Technologies Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on GE HealthCare Technologies Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on GE HealthCare Technologies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GE HealthCare Technologies Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-05 | Reported | not named in the filing | 8-K, 2026-11-05 | ||
| 2026-10-28 | Out | President | 8-K, 2026-10-28 | ||
| 2026-09-22 | In | Director | 2027-01-04 | 8-K, 2026-09-22 | |
| 2026-08-18 | In | Chief Financial Officer | 2026-09-14 | 8-K, 2026-08-18 | |
| 2026-07-23 | In | Chief Financial Officer | 2026-08-14 | 8-K, 2026-07-23 |
Who leads GE HealthCare Technologies Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Pascal Desroches, appointed, effective 2027-01-04 (filed 2026-09-22).
- President: Jeannette Bankes, departure reported (filed 2026-10-28). No successor is named in these filings.
- Chief Financial Officer: William K. Grogan, appointed, effective 2026-09-14 (filed 2026-08-18).
New leaders reset buying decisions — get the Full Report on GE HealthCare Technologies Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at GE HealthCare Technologies Inc., with the record behind each one.
Find candidates like President at GE HealthCare Technologies Inc.Every change, in the filing's words
Reported
On November 4, 2026, Taha Kass-Hout notified GE HealthCare Technologies Inc. ("GE HealthCare") that he will resign as Chief Science and Technology Officer.
- Mr. Kass-Hout's last day at GE HealthCare will be December 31, 2026.
Departing: Jeannette Bankes, President
On October 22, 2026, Jeannette Bankes notified GE HealthCare that she will resign as President and CEO, Patient Care Solutions.
- Ms. Bankes' last day at GE HealthCare will be November 15, 2026.
Appointed: Pascal Desroches, Director, effective 2027-01-04
On September 22, 2026, the Board of Directors (the "Board") of GE HealthCare Technologies Inc. (the "Company") appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027.
- The Board also appointed Mr. Desroches as a member of the Audit Committee and the Talent, Culture, and Compensation Committee of the Board, effective January 4, 2027.
- Upon joining the Board, Mr. Desroches will receive compensation in accordance with the Company's compensation program for non-employee directors, which is described in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on March 19, 2026.
- The Company will also enter into an indemnification agreement with Mr. Desroches.
Appointed: William K. Grogan, Chief Financial Officer, effective 2026-09-14
On August 13, 2026, the Board of Directors (the "Board") of GE HealthCare Technologies Inc. ("GE HealthCare") appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.
- George A. Newcomb, who currently serves as GE HealthCare's interim Chief Financial Officer, will cease serving in that interim role on September 14, 2026, and will continue serving as GE HealthCare's Controller and Chief Accounting Officer.
- Mr. Grogan, age 48, has served as Executive Vice President and Chief Financial Officer of Xylem Inc., a global water solutions company, since October 2023.
- Previously, Mr. Grogan served as Senior Vice President and Chief Financial Officer of IDEX Corporation, a global engineered products company, from January 2017 until September 2023.
- On August 13, 2026, the Talent, Culture, and Compensation Committee (the "Committee") of the Board approved Mr. Grogan's compensation after considering a variety of factors, including Mr. Grogan's experience and skills, data and advice from its independent compensation consultant, the compensation Mr. Grogan will forfeit at his current employer, and GE HealthCare's Total Rewards Philosophy.
- Mr. Grogan's offer letter provides for an annual base salary of $900,000, target annual bonus opportunity equal to 100% of base salary, an annual long-term incentive ("LTI") award with a target grant date value of $3,300,000, and participation in GE HealthCare's benefit plans, including its Retirement Savings Plan, Restoration Plan, and US Severance and Change in Control Plan for CEO and Leadership Team (the "Severance Plan").
Appointed: George Newcomb, Chief Financial Officer, effective 2026-08-14
On July 23, 2026, GE HealthCare named George Newcomb, Controller and Chief Accounting Officer, as interim Chief Financial Officer, effective August 14, 2026.
- Departure of Directors or Certain Officers On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.
- Mr. Saccaro's last day at GE HealthCare will be August 14, 2026.
- Mr. Newcomb will continue to serve as Controller and Chief Accounting Officer.
- GE HealthCare has commenced a search for a permanent successor.
- Mr. Newcomb, age 59, served as the Controller of the healthcare business of General Electric Company ("GE") beginning in February 2016 and was named as Controller and Chief Accounting Officer of GE HealthCare in January 2023 in connection with the spin-off of GE HealthCare from GE.
- From 1996 through February 2016, he held a variety of finance leadership roles at GE Capital, including Capital Planning and Finance Readiness Leader of GE Capital Americas ("GECA"), Controller of GECA, and Chief Financial Officer roles at Bank BPH, GE Capital Equipment Finance, and GE Capital Healthcare Financial Services.
- Prior to GE Capital, he was a Senior Tax Manager at Arthur Andersen.
- There are no changes to the compensation arrangements for Mr. Newcomb in connection with becoming interim Chief Financial Officer.
Tools for this story
Each opens in a new tab, filled in for GE HealthCare Technologies Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.